In a 2024 paper published in Rheumatology, Tambiah and colleagues conducted a review analysis of two phase 2 trials and two phase 3 trials of intra-articular lorecivivint in patients with knee OA.

“Participants will gain critical insights into effectively handling Board Room dynamics, strategically aligning themselves for career growth, networking across different dimensions, developing their ...